Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside

Immune checkpoint inhibitors have transformed the landscape of oncological therapy, but at the price of a new array of immune related adverse events. Among these is β-cell failure, leading to checkpoint inhibitor-related autoimmune diabetes (CIADM) which entails substantial long-term morbidity. As o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Linda, Tsang, Venessa H. M., Sasson, Sarah C., Menzies, Alexander M., Carlino, Matteo S., Brown, David A., Clifton-Bligh, Roderick, Gunton, Jenny E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603930/
https://www.ncbi.nlm.nih.gov/pubmed/34803927
http://dx.doi.org/10.3389/fendo.2021.764138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603930/
https://www.ncbi.nlm.nih.gov/pubmed/34803927
http://dx.doi.org/10.3389/fendo.2021.764138

Ejemplares similares